FDA approves gene therapy for children with sickle cell disease ages 2+

FDA approves gene therapy for children with sickle cell disease ages 2+
FacebookXWhatsAppEmail

The Food and Drug Administration recently approved gene therapy to treat sickle cell disease among children ages 2 and older, which a Nashville doctor described as a medical milestone.